8.40 pm | 23 May 2013 |  Source: CNBC-TV18

CNBC-TV18 executive editor Shereen Bhan and Archana Shukla reports that Malvinder Singh, while denying all wrong-doing at Ranbaxy, says that Daiichi t...

7.00 pm | 23 May 2013 |  Source: CNBC-TV18

CNBC-TV18's market experts advise investors to stay with the short bias on the markets amd avoid bank-stocks till expiry of the May series....

5.39 pm | 23 May 2013 |  Source: CNBC-TV18

According to Dynamix Research & Capital Management’s CEO Sanjeev Agarwal, Ranbaxy may see a pullback around Rs 440-450. He said that would be a leve...

5.33 pm | 23 May 2013 |  Source: CNBC-TV18

Eastern Financiers’ Head of Research Rajesh Agarwal recommended selling Ranbaxy Labs. He said he wouldn’t be surprised if this stock falls below R...

4.35 pm | 23 May 2013 |  Source: Reuters

"Daiichi Sankyo believes that certain former shareholders of Ranbaxy Laboratories concealed and misrepresented critical information concerning the US ...

3.30 pm | 23 May 2013 |  Source: Moneycontrol.com

Ranbaxy slumped on Thursday after some reports said the Indian government too has initiated an investigation into its past documents and applications ...

8.46 am | 23 May 2013 |  Source: CNBC-TV18

Balmer Lawrie | Jai Corp | India Cements | SREI Infra | Jyothy Labs | Geojit BNP | NCC | Thermax | Puravankara Projects | Ranbaxy Labs and Fortis Heal...

8.09 pm | 22 May 2013 |  Source: CNBC-TV18

Diiachi says that certain former shareholders "misrepresented critical information". ...

2.23 pm | 22 May 2013 |  Source: CNBC-TV18

Bino Pathiparampil of IIFL Capital told CNBC-TV18 that there has been a major rally in the sector over the last couple of years. Thus, many of the sto...

8.40 am | 22 May 2013 |  Source: CNBC-TV18

Ramco Systems | Shree Renuka | Ranbaxy Labs | Tech Mahindra | JSW Ispat Steel | Prestige Estates | Subex | JK Paper | Bharti Airtel | Oracle Financial...

7.17 pm | 21 May 2013 |  Source: CNBC-TV18

Sharmila Joshi, Head of Equity, Peerless Securities is of the view that one can switch to Cipla from Ranbaxy Laboratories....

2.11 pm | 21 May 2013 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one can sell Ranbaxy Laboratories....

9.13 am | 21 May 2013 |  Source: CNBC-TV18

Manas Jaiswal of manasjaiswal.com has recommended a buy rating on Adani Power and Dena Bank. ...

8.31 pm | 20 May 2013 |  Source: CNBC-TV18

Kunal Bothra, Sr Technical Analyst of LKP is of the view that, if Ranbaxy Laboratories breaks at Rs 440 level in the next couple of days the short-ter...

7.22 pm | 20 May 2013 |  Source: CNBC-TV18

SP Tulsian of sptulsian.com is of the view that one can short Adani Enterprises with a target of Rs 239."Short Ranbaxy Laboratories with a target of R...

7.00 pm | 20 May 2013 |  Source: Moneycontrol.com

At first glance, it appeared the new Drug Pricing Control Order was to blame. But there were other factors as well. Here are the reasons…...

1.00 pm | 20 May 2013 |  Source: Moneycontrol.com

Brokerage house HSBC has released a note on the new drug price control order (DPCO) and its impact on the Indian pharma companies. The broking firm be...

11.48 am | 17 May 2013 |  Source: Reuters

The policy, which will curtail prices of costly brands sold by domestic and international drugmakers, was approved by the government in November....

10.36 am | 17 May 2013 |  Source: Moneycontrol.com

The Department of Pharmaceuticals on Thursday notified Drug Price Control Order 2013. Once implemented over next few months, prices of 348 essential d...

7.19 pm | 15 May 2013 |  Source: CNBC-TV18

CNBC-TV18’s Archana Shukla takes a closer look at Dinesh Thakur, the man who blew the whistle on Ranbaxy, and kicked off a legal battle that other g...